Cambridge Healthtech Institute’s Third Annual 

Genomic Sample Prep and Biomarker Assay Development

DNA/RNA Extraction, NGS Assays, Liquid Biopsy, Antibody Validation, & More

March 7-9, 2016 | Moscone North Convention Center | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference

 

The final goal of any assay development is to assure its intra- and inter-laboratory reproducibility and accuracy. This goal can be reached by innovative assay development and its careful validation. Appropriate and novel sample preparation is a pivotal part of assay development and validation that guarantees its repeatability and robustness. Novel sample preparation technologies have the ability to significantly increase sensitivity and specificity of a test that is run on a heterogeneous sample or a sample that contains a low concentration of analyte. Cambridge Healthtech Institute’s Third Annual Sample Prep and Diagnostics Assay Development conference is designed to bring together leading industry and academia experts in biospecimen science and molecular diagnostics to discuss major challenges and latest advances in sample preparation for advanced omics technologies as well as development and validation of NGS and other novel diagnostics assays.

Who should attend: Diagnostics industry researchers and laboratory medicine professionals working on development and validation of new diagnostics assays.

Topics will include, but are not limited to:

  • General pre-analytical issues in clinical diagnostics and molecular pathology
  • Quantitative assessment of pre-analytic variables
  • Novel nucleic acid extraction technologies
  • Matching nucleic acid extraction method with the goal of an assay
  • Collection, processing, and storage of samples;
  • IT technologies for sample management
  • NGS clinical assay development and validation
  • Sample prep considerations for NGS assays and qPCR assays
  • Proteomics assay development and validation
  • Technical aspects of liquid biopsy assays
  • Antibody validation for cancer immunotherapy biomarkers
  • Clinical cell-based assays development
  • Overcoming pre-analytical issues with archived FFPE samples
  • Sample considerations in biomarker driven clinical trials
  • Automated tissue sample preparation
  • Smaller sample preparation devices/ nanotechnology applications for diagnostics
  • Pre-capture multiplex target enrichment
  • Target enrichment in genetically heterogeneous tumor samples
  • Microbiology sample prep and target enrichment
  • Label-free assays and sample-to-result technologies

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is August 28, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Marina Filshtinsky, M.D.
Senior Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5496
E: mfilshtinsky@healthtech.com

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com

Premier Sponsors:  

Bina Technologies

Coyote

Elsevier   

Jackson Laboratory - small logo 

 NanoString2   

 Precision for Medicine 

SeraCare(2)

Silicon Biosystems

Thomson Reuters-Large